CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Adult T-cell Leukemia-Lymphoma
Kyowa Kirin Co., Ltd.Small moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Adult T-cell Leukemia-Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
MOGAMULIZUMAB Memorial Sloan Kettering Cancer Center | Phase 2 | BB |
CIS-DIAMMINEDICHLOROPLATINUM II Kyowa Kirin, Inc. | Phase 2 | BB |
Cytosin-Arabinosid Fred Hutchinson Cancer Center | Phase 2 | BB |
Eloxatin Kyowa Kirin, Inc. | Phase 2 | B |
Pralatrexate Kyowa Kirin, Inc. | Phase 2 | B |
View all 10 →
Same molecule, other indications
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →